Contingent Value Rights Agreement between Lantheus Holdings, Inc. and Computershare Inc. Computershare Trust Company, N.A. collectively, as Rights Agent Dated as of June 19, 2020Contingent Value Rights Agreement • June 22nd, 2020 • Lantheus Holdings, Inc. • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledJune 22nd, 2020 Company Industry JurisdictionTHIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of June 19, 2020 (this “Agreement”), is entered into by and between Lantheus Holdings, Inc., a Delaware corporation (“Lantheus”), and Computershare, Inc. (“Computershare”), a Delaware corporation, and its wholly owned subsidiary, Computershare Trust Company, N.A., a federally chartered trust company (collectively, the “Rights Agent”).
Form of Contingent Value Rights Agreement between Lantheus Holdings, Inc. and as Rights Agent Dated as of [●], 2020Contingent Value Rights Agreement • February 20th, 2020 • Lantheus Holdings, Inc. • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledFebruary 20th, 2020 Company Industry JurisdictionTHIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [•], 2020 (this “Agreement”), is entered into by and between Lantheus Holdings, Inc., a Delaware corporation (“Lantheus”), and [•], a [•] (the “Rights Agent”).